Asymchem Laboratories (Tianjin) Co., Ltd. (FRA:7K90)
Germany flag Germany · Delayed Price · Currency is EUR
8.40
-0.10 (-1.18%)
At close: Feb 20, 2026
Market Cap4.31B +28.2%
Revenue (ttm)753.54M +12.8%
Net Income124.37M +35.1%
EPS0.34 +32.4%
Shares Outn/a
PE Ratio34.69
Forward PE25.77
Dividend0.13 (1.55%)
Ex-Dividend DateJun 25, 2025
Volumen/a
Average Volumen/a
Open8.40
Previous Close8.50
Day's Range8.40 - 8.40
52-Week Range4.50 - 12.30
Betan/a
RSI45.22
Earnings DateMar 31, 2026

About FRA:7K90

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing... [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 9,595
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 7K90
Full Company Profile

Financial Performance

In 2024, FRA:7K90's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial numbers in CNY Financial Statements